Fraser, Christopher,Kishimoto, Takashi Kei,Maldonado, Roberto A.
申请号：
AU2012249401
公开号：
AU2012249401A1
申请日:
2012.04.27
申请国别(地区):
AU
年份:
2013
代理人:
摘要：
Disclosed are synthetic nanocarrier methods, and related compositions, comprising administering immunosuppressants and MHC Class I-restricted and/or MHC Class II- restricted epitopes that can generate tolerogenic immune responses (e.g., antigen- specific T effector cell deletion).
